Original article

Influence of different diagnostic criteria on the prevalence of hypertension in the population

Expand
  • 1a. Department of Cardiology; b. Department of Geriatrics, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai 200233, China
    2. Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, Shanghai 200032, China

Received date: 2022-01-21

  Online published: 2022-08-08

Abstract

Objective To compare the difference in the prevalence of hypertension diagnosed with the 2017 American hypertension diagnostic criteria (American standard) and the Chinese guidelines for the prevention and treatment of hypertension (2018 revised edition, Chinese standard) in the general population. Methods The cluster stratified random sampling method was adopted. The population samples were collected from the population database of physical examination between 2015 and 2019 in Shanghai Sixth People’s Hospital and were stratified by every 10 years. Twenty people including 10 males and 10 females were randomly selected from every year, which was defined as one layer. The information of investigation included medical history investigation, height, weight, blood pressure measurement, blood biochemical index detection, etc. Both the items and information of the physical examination adopted unified and standardized testing methods. According to the definition of hypertension in China standard [≥140/90 mmHg (1 mmHg=0.133 kPa) or taking antihypertensive drugs right now]and in American standard(≥130/80 mmHg or taking antihypertensive drugs right now), the prevalence of hypertension in people in different genders and ages were calculated, respectively. Results The population prevalence of hypertension based on Chinese standard was 27.3%(29.0% in male and 25.7% in female); the population prevalence of hypertension based on American standard was 55.8% (65.3% in men and 46.3% in women); the systolic blood pressure showed a linear increase with age, while the diastolic blood pressure showed an inverted“U” distribution with age; the prevalence of hypertension based on both definitions increased with age in 6 age groups, which were 20-29, 30-39, 40-49, 50-59, 60-69 and 70-79 years. Furthermore, the age groups of 50-59 and 60-69 showed the largest differences in two diagnostic criteria, with an increase of 37.0% and 39.0%, respectively. The prevalence of hypertension in male was higher than female in most age groups except the groups of 60-69 and 70-79 years in Chinese standard and the group of 70-79 years in American standard (all P<0.05). The two diagnostic criteria led to large difference in the diagnostic rate of hypertension in male. Conclusions According to 2017 American standard, the prevalence of Chinese young and middle-aged people diagnosed as hypertension increased significantly compared to Chinese standard of 2018. Therefore, more attention should be given to this group, and the lifestyle and medical interventions should be carried out early to reduce the risk of cardiovascular and cerebrovascular diseases.

Cite this article

LI Xinni, MA Wenkun, GAO Chengjie, GAO Yajie, JIN Xuejuan, ZHOU Yi, SHEN Chengxing, PAN Jingwei . Influence of different diagnostic criteria on the prevalence of hypertension in the population[J]. Journal of Internal Medicine Concepts & Practice, 2022 , 17(04) : 273 -277 . DOI: 10.16138/j.1673-6087.2022.04.001

References

[1] Marczak L, Williams J, Loeffler M, et al. Global deaths attributable to high systolic blood pressure, 1990-2016[J]. JAMA, 2018, 319(21): 2163.
[2] Lewington S, Lacey B, Clarke R, et al. The burden of hypertension and associated risk for cardiovascular mortality in China[J]. JAMA Intern Med, 2016, 176(4): 524-532.
[3] 刘力生, 吴兆苏, 王继光, 等. 中国高血压防治指南(2018年修订版)[J]. 中国心血管杂志, 2019, 24(1): 24-56.
[4] Wang Z, Chen Z, Zhang L, et al. Status of hypertension in China: results from the China Hypertension Survey, 2012-2015[J]. Circulation, 2018, 137(22): 2344-2356.
[5] Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/ AHA/ AAPA/ ABC/ ACPM/ AGS/ APhA/ ASH/ ASPC/ NMA/ PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults[J]. J Am Coll Cardiol, 2018, 71(19): e127-e248.
[6] Qi Y, Han X, Zhao D, et al. Long-term cardiovascular risk associated with stage 1 hypertension defined by the 2017 ACC/AHA hypertension guideline[J]. JACC, 2018, 72(11): 1201-1210.
[7] 赵冬. 美国2017年高血压诊断标准有助于高血压防治理念与时俱进[J]. 协和医学杂志, 2019, 10(2): 117-121.
[8] Yang C, Wang JW, Gao B, et al. Prevalence and treatment of hypertension in China: impacts of 2017 American College of Cardiology/American Heart Association High Blood Pressure Guideline[J]. Sci Bull, 2018, 63(8): 488-493.
[9] Khera R, Lu Y, Lu J, et al. Impact of 2017 ACC/AHA guidelines on prevalence of hypertension and eligibility for antihypertensive treatment in United States and China: nationally representative cross sectional study[J]. BMJ, 2018, 362: k2357.
[10] Vaucher J, Marques-Vidal P, Waeber G, et al. Population impact of the 2017 ACC/AHA guidelines compared with the 2013 ESH/ESC guidelines for hypertension management[J]. Eur J Prev Cardiol, 2018, 25(10): 1111-1113.
[11] Huang Y, Cai X, Liu C, et al. Prehypertension and the risk of coronary heart disease in Asian and Western populations: a meta-analysis[J]. J Am Heart Assoc, 2015, 4(2): e001519.
[12] Habib GB, Virani SS, Jneid H,. Is 2015 the prime time year for prehypertension? Prehypertension: a cardiovascular risk factor or simply a risk marker?[J]. J Am Heart Assoc, 2015, 4(2): e001792.
Outlines

/